Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone gel for cognition in older postmenopausal women
ACTRN12609000981224Phase 2Completed
- Sponsor
- Monash University
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in No canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity comparing Libigel testosterone gel with Placebo gel (2 arms). Primary endpoint: Cognitive performance. Started Mar 2010; status: completed.
02
Drugs
testosterone
03
Conditions
No canonical disease name; "cognitive deterioration" is a descriptive term, not a recognized disease entity.
Beyond the preview
Go deeper on ACTRN12609000981224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000981224.